Niagen Bioscience对外释放积极信号,表示其旗舰产品Niagen Plus的持续增长以及一系列全新的护肤品战略合作,预计将从2027年开始,逐步转化为公司业绩中举足轻重的贡献者。这一预期标志着公司对未来增长引擎的清晰布局。
Niagen Bioscience对外释放积极信号,表示其旗舰产品Niagen Plus的持续增长以及一系列全新的护肤品战略合作,预计将从2027年开始,逐步转化为公司业绩中举足轻重的贡献者。这一预期标志着公司对未来增长引擎的清晰布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.